Stock ONCSQ ONCOSEC MEDICAL INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Financials OncoSec Medical Incorporated

Equities

ONCSQ

US68234L4059

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 01:02:33 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.0003 USD +50.00% Intraday chart for OncoSec Medical Incorporated +50.00% +29,900.00%
2023 Motion for Asset Sale Approved for OncoSec Medical Incorporated CI
2023 Motion for Asset Sale Filed by OncoSec Medical Incorporated CI

Valuation

Fiscal Period: July 2017 2018 2019 2020 2021 2022
Capitalization 1 21.8 64.91 23.68 96.73 85.42 28.35
Enterprise Value (EV) 1 10.36 37.93 -1.389 84.2 51.79 27.23
P/E ratio -0.97 x -1.27 x -0.52 x -1.64 x -1.59 x -0.83 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -0.49 x -1.06 x 0.05 x -1.95 x -1.09 x -0.74 x
EV / FCF -1.1 x -3.68 x 0.08 x -4.82 x -1.92 x -1.26 x
FCF Yield -91% -27.2% 1,214% -20.8% -52% -79.5%
Price to Book 2.08 x 2.89 x 0.98 x 6.98 x 2.24 x 4.64 x
Nbr of stocks (in thousands) 96.2 238 483 1,047 1,781 1,789
Reference price 2 226.6 272.8 49.06 92.40 47.96 15.84
Announcement Date 10/25/17 10/19/18 10/28/19 10/28/20 10/29/21 10/31/22
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: July 2017 2018 2019 2020 2021 2022
Net sales - - - - - -
EBITDA 1 -21.07 -35.77 -29.77 -43.19 -47.35 -36.75
EBIT 1 -21.45 -36.11 -30.02 -43.41 -47.58 -37.01
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -21.45 -39.14 -30.27 -43.13 -47.58 -37.51
Net income 1 -21.45 -39.14 -30.28 -42.25 -45.17 -34.18
Net margin - - - - - -
EPS 2 -233.7 -214.6 -94.43 -56.22 -30.20 -19.13
Free Cash Flow 1 -9.43 -10.32 -16.86 -17.49 -26.91 -21.63
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 10/25/17 10/19/18 10/28/19 10/28/20 10/29/21 10/31/22
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: July 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales 1 - - - - - - - - -
EBITDA - - - - - - - - -
EBIT 1 -13.04 -11.03 -10.44 -13.88 -9.915 -9.416 -9.548 -8.132 -7.307
Operating Margin - - - - - - - - -
Earnings before Tax (EBT) 1 -13.22 -10.7 -9.441 -14.21 -9.809 -9.904 -9.584 -8.216 -8.061
Net income 1 -13.23 -10.7 -9.442 -11.8 -9.809 -9.907 -6.247 -8.216 -8.061
Net margin - - - - - - - - -
EPS 2 -10.78 -8.140 -5.500 -6.380 -5.500 -5.500 -3.520 -4.620 -4.500
Dividend per Share - - - - - - - - -
Announcement Date 12/11/20 3/15/21 6/11/21 10/29/21 12/15/21 3/15/22 6/14/22 10/31/22 12/15/22
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: July 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 11.4 27 25.1 12.5 33.6 1.12
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -9.43 -10.3 -16.9 -17.5 -26.9 -21.6
ROE (net income / shareholders' equity) -111% -233% -128% -222% -174% -155%
ROA (Net income/ Total Assets) -56.3% -99.2% -62.4% -90.7% -69% -59.2%
Assets 1 38.11 39.44 48.53 46.56 65.44 57.74
Book Value Per Share 2 109.0 94.20 50.20 13.20 21.40 3.420
Cash Flow per Share 2 116.0 15.60 52.00 19.40 25.80 6.870
Capex 1 0.02 0.07 0.01 - 0.3 0.24
Capex / Sales - - - - - -
Announcement Date 10/25/17 10/19/18 10/28/19 10/28/20 10/29/21 10/31/22
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
ONCOSEC MEDICAL INCORPORATED Stock OncoSec Medical Incorporated
+29,900.00% 1.79K
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.17% 42.86B
MODERNA, INC. Stock Moderna, Inc.
+10.92% 42.74B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 41.36B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+5.23% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.79% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.69% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.13% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.57% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ONCSQ Stock
  4. Financials OncoSec Medical Incorporated